My ramblings on the SELECT-GCA study and predictions of the place of upadacitinib in clinical practice in GCA are up now on RheumNow #ACR24 @RheumNow https://t.co/DR5VgVmdse

• SELECT-GCA: Efficacy and Safety of Upadacitinib | RheumNow

I've shared some further thoughts on @jeffsparks SAIL-RA study and its finding of the strong association of RA-ILD with disease activity in early RA. And of course couldn't resist going on a tangent about the ACR ILD guidelines! #ACR24 @RheumNow https://t.co/UUDbWw38Im

• Disease Activity in RA-ILD | RheumNow

A key practice changing study (I hope) from #ACR24 has been the preCARA study. Fertility increases with aggressive disease control. My video on this study is up now on @RheumNow https://t.co/Pf3rdTHbOJ

• Treat-to-Target Improves Fertility in Women with RA | RheumNow

RheumNow Day 2 Recap: ACR Convergence 2024 Highlights https://t.co/YAwOEaNsWs

• Dr. John Cush

To stop tsDMARD / bDMARD To improve #COVIDVACCINE response in those w several previous #COVID19 #vaccinations is NOT necessary This will change my practice! #ACR24 @RheumNow @ACRheum https://t.co/WXeqMOEfuA

• https://twitter.com/healiorheum/status/1858268880310874586

The anti-MCTD group strikes back Of cohort of over 1,000 RNP+ pt, only 17 clinically diagnosed with MCTD Majority of patients, despite potential overlap, treated for other primary rheum dz @RheumNow #ACR24 https://t.co/vkQ6UPs34y

• https://x.com/Dr_Brian_MD/status/1858261782160351458/photo/1

Older RA patients in RISE with high disease activity show a higher incidence of hip and major osteoporotic fractures. Practice T2T and monitor bone health closely! #ACR24 @RheumNow ABST#1748 https://t.co/7MCAIrfXhp

• https://x.com/JihaRheum/status/1858263593927778331/photo/1

How does #race & #ethnicity impact mortality in RA? Study in CDC national mortality database ➡️RA mortality differed by race & ethnicity ➡️Highest premature mortality in Native Americans Findings may be used to inform resource allocation & management Ab1747 #ACR24 @RheumNow